These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16685163)

  • 1. [Practical procedure of totally implanted venous access system for outpatient cancer therapy].
    Iida S; Egami K; Sasajima K; Hasegawa H; Miyamoto M; Yokoyama T; Suzuki S; Tajiri T
    Gan To Kagaku Ryoho; 2006 May; 33(5):639-43. PubMed ID: 16685163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical outcome of totally implantable subcutaneous infusion port--comparison with home parenteral nutrition and chemotherapy].
    Taniguchi K; Oka K; Tokuyasu N; Naka T; Kondo A; Tsujitani S; Ikeguchi M
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):281-5. PubMed ID: 18281766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Our outpatient cases for home anti-cancer chemotherapy using a CV port and a portable pump system].
    Midorikawa Y; Nakachi T; Kasuga T
    Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():264-6. PubMed ID: 17469355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central venous access port-related complications in outpatient chemotherapy for colorectal cancer.
    Inaba Y; Yamaura H; Sato Y; Najima M; Shimamoto H; Nishiofuku H; Ura T; Muro K
    Jpn J Clin Oncol; 2007 Dec; 37(12):951-4. PubMed ID: 18057011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.
    Kreis H; Loehberg CR; Lux MP; Ackermann S; Lang W; Beckmann MW; Fasching PA
    Eur J Surg Oncol; 2007 Feb; 33(1):39-43. PubMed ID: 17029869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with an implantable venous access system for chemotherapy.
    Pettengell R; Davies AJ; Harvey VJ
    N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Totally implantable systems in oncology: the cephalic vein as an elective access port].
    Di Giorgio A; Bangrazi C; Canavese A; Arnone P; Corsetti FB; Pallotti M; al Mansour M
    Ann Ital Chir; 1997; 68(4):529-36; discussion 536-7. PubMed ID: 9494185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Satisfaction versus dissatisfaction with venous access devices in outpatient oncology: a pilot study.
    Chernecky C
    Oncol Nurs Forum; 2001; 28(10):1613-6. PubMed ID: 11759308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A total subcutaneously implantable venous catheter system. 4 years' experience in cancer patients].
    Ludwig R; Ludwig CU; Laffer U; Stoll HR; Obrecht JP
    Schweiz Med Wochenschr; 1988 Mar; 118(9):305-8. PubMed ID: 3358106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outpatient diuretic treatment of terminal heart failure by a completely implantable venous infusion system].
    Langes K; Siebels J; Carnarius H; Weiss C; Kuck KH; Nienaber CA
    Z Kardiol; 1993 Nov; 82(11):737-41. PubMed ID: 7507287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implantable catheter system for ambulatory parenteral antibiotic chemotherapy. A prospective study].
    Laffer U; Dürig M; Zimmerli W; Stoll HR; Landmann J
    Helv Chir Acta; 1989 Jun; 56(1-2):127-31. PubMed ID: 2777591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trial of "Huber Plus" in outpatients with chemotherapy by blood port system].
    Matsumura N; Tazumi K; Kouji K; Kondo M; Mizuki M
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):539-41. PubMed ID: 18347413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
    Ferranti F; Chichi GL; Mazzola L; Triveri P; Palmieri RM
    G Chir; 2002 May; 23(5):225-8. PubMed ID: 12228978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What do cancer chemotherapy outpatients want?--results of a questionnaire survey].
    Uramoto H; Kabashima M; Yamazaki K; Kadota T; Narimatsu M; Iwashige A; Kagami S; Tsukada J
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1681-3. PubMed ID: 17108742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Using a pleural implantable access system for the management of malignant pleural effusions. Experience of Institut Curie].
    Daniel C; Kriegel I; Di Maria S; Patrubani G; Livartowski A; Estève M
    Rev Pneumol Clin; 2008 Feb; 64(1):8-14. PubMed ID: 18603173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The future of chemotherapy at home--from outpatient chemotherapy to chemotherapy at home].
    Takahashi K
    Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():279-81. PubMed ID: 17469360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our outpatient cases for home anti-cancer chemotherapy].
    Midorikawa Y; Suzuki K; Kasuga T; Takemura A
    Gan To Kagaku Ryoho; 2005 Dec; 32 Suppl 1():1-3. PubMed ID: 16422472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences of implantable vascular access device, "Vital Port" for arterial infusion chemotherapy].
    Takayasu Y; Kumada T; Ito K
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1283-8. PubMed ID: 10478181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.